Ambu A/S held its annual general meeting on 10 December 2015. The shareholders approved the distribution of the profit for the year 2015 and dividend of DKK 0.95 per share will consequently be distributed, corresponding to 30% of the net profit.

The shareholders elected Henrik Ehlers Wulff and Oliver Johansen as new members of the Board. Jesper Funding Andersen and John Stær are not up for re-election. Henrik Ehlers Wulff is Executive Vice President, Novo Nordisk Product Supply. Henrik has been with Novo Nordisk since 1998 where he has held a number of management positions. In 2015, he was appointed Executive Vice President and became a member of the Executive Management. Henrik Wulff has served as a member of the Board of Directors of Novo Nordisk PharmaTech A/S several times since 2009, for the past two years as chairman. He is also a member of the Board of Directors of NNE Pharmaplan A/S. Oliver Johansen Senior Vice President Global Research & Development, Chronic Care in Coloplast. Oliver Johansen has been with Coloplast since 2002, initially joining as Logistics Manager. In 2007, he was appointed VP, Supply Chain Management and International Manufacturing, Global Operations. Oliver Johansen is a member of the Board of Directors of Acarix.